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Abstract 
Background: Sexual function is often affected in patients suffering from chronic diseases especially chronic obstruc‑
tive pulmonary disease (COPD). However, the effect of COPD on sexual satisfaction is underappreciated in clinical 
practice. The aim of this study is to evaluate the impact of COPD on patient’s sexuality and the explanatory variables 
of sexual dissatisfaction.
Methods: Questionnaires were emailed to participants and they submitted their responses on the Santé Respiratoire 
France website. Data about sexual well‑being (Arizona Sexual Experience Scale, ASEX), Quality of life (VQ11), anxiety, 
depression (Hospitalized anxiety and depression, HAD) and self‑declared COPD grade were collected.
Results: Seven hundred and fifty one subjects were included and were characterized as follows: women—51%, 
mean age—61 years, in a couple—62% and 70%—retired. Every grade of COPD was represented. Out of 751 par‑
ticipants, 301 participants (40%) had no sexual activity and 450 (60%) had sexual activity. From the 450 participants, 
60% needed to change their sexual life because of their disease (rhythm, frequency and position). Subjects often 
used medications to improve sexual performance (43% used short‑acting bronchodilator and 13% ‑specific erectile 
dysfunction drugs). ASEX questionnaire confirmed patients’ dissatisfaction (diminution of sexual appetite for 68% and 
sexual desire for 60%) because of breathlessness and fatigue. Eighty one percent of the responders had an altered 
quality of life (VQ11 mean score 35) and frequent suspected anxiety or depression (HAD mean score 10.8). Ninety per‑
cent declared that sexual dysfunction had never been discussed by their doctors, while 36% of patients would have 
preferred to undergo a specialized consultation.
Conclusion: Sexual dysfunction is frequent among COPD patients and leads to an altered well‑being, however being 
a cultural taboo, it remains frequently neglected. Sexual guidance should be a part of patient’s consultations improve 
quality of sexual life.
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Background
Sexual function is often affected in individuals living 
with chronic illness, and multiple comorbidities increase 
the likelihood of sexual dysfunction. The World Health 
Organization (WHO) has defined sexual health as a state 
of physical, mental and social well-being in relation to 
sexuality [1]. Good sexual health requires a positive and 
respectful approach to sexuality and sexual relationships, 
as well as the possibility of having pleasurable and safe 
sexual experiences, free of coercion, discrimination and 
violence. It also requires freedom from organic disorders 
and diseases that interfere with sexual and reproductive 
functions. However, chronic obstructive pulmonary dis-
ease (COPD) is progressive disorder characterized by 
airflow limitation that is not fully reversible, and is often 
accompanied by decreased quality of life (QoL) [2]. Sex-
ual function is a QoL aspect that is markedly affected in 
subjects with COPD [3–7] as the accompanying respira-
tory or physical symptoms, such as dyspnea, weakness, 
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fatigue and reduced physical activity have an adverse 
effect on sexual activity [8–10].
Despite these detrimental consequences, the effect of 
COPD on sexual satisfaction is underappreciated in clini-
cal practice, partly because patients often feel uncom-
fortable talking about their sexuality with healthcare 
providers [3, 4, 7, 11] but also because healthcare provid-
ers are reluctant to address these issues.
The primary aim of this study was to evaluate the dis-
ease’s impact on patients’ sexuality among subjects liv-




Online survey was assessed from March to May 2019 
through the association Santé Respiratoire France (https 
://sante -respi ratoi re.com). Four pulmonologists, one sex-
ologist, one expert patient and one psychiatrist developed 
the questionnaire. The following data were collected at 
inclusion: demographic characteristics (age, gender, mar-
ital or relationship status, occupation, living area: urban, 
suburban, rural), smoking history, breathlessness and 
exacerbations etc.).
A detailed description of the questionnaires is available 
in Additional file 1.
Arizona sexual experience scale (ASEX)
Sexual experience was assessed using the 4-item Arizona 
Sexual Experience Scale (ASEX-French version), owing 
to its reliability, validity and easy administration [12]. It 
allows for the assessment of four major global aspects of 
sexual dysfunction: sexual appetite/ drive, sexual desire/ 
arousal, penile erection/vaginal lubrication and satisfac-
tion from orgasm. Higher scores indicate poor sexual 
function [12].
VQ11
Quality of life was evaluated by VQ11 which is intended 
to assess diverse components of quality of life (functional: 
3 items, psychological: 4 items, social: 4 items), through 
11 questions, with a rating from 1 to 5, with higher scores 
indicating decreased quality of life [13, 14].
Hospitalized anxiety and depression (HAD)
HAD scale allows for the detection of depression and/
or anxiety through 14 items rated from 0 to 3, based on 
symptom frequency (higher frequency equating to higher 
scores). A score of 11 or more indicates probable pres-
ence of an altered mood [15].
Fatigue severity scale (FSS)
The FSS is a questionnaire with nine questions estimat-
ing the fatigue severity in different situations during 
the past week. Grading ranges from 1 (strong disagree-
ment) to 7 (strong agreement) where the final score 
is the mean value of the nine items, and a score ≥ 4 is 
interpreted as fatigue [16]. FSS scale has been validated 
in COPD [17, 18].
Once the questionnaire was completed and tested, 
it was then emailed to every member of BPCO asso-
ciation. Followed by completion of the survey data by 
anonymous volunteers, to respect the clause: “strength-
ening the reporting of observational studies in epidemi-
ology” (STROBE) statement [19]. COPD was validated 
by a spirometry and by a physician-diagnosis.
Mapping psychological profiles
We carried out a typological analysis to split the studied 
population into distinct homogeneous groups depend-
ing on their responses to the various questionnaires. 
We conducted latent class and profile analyses of CODP 
burden and respiratory assistance (dyspnea, fatigue) 
and psychological symptoms (depression and anxi-
ety) to identify distinct classes (subgroups) of symp-
tom profiles [20]. Patients were assigned a probability 
of being in each of the identified classes with the goal 
of creating a model that uniquely assigned a subject to 
a given class (e.g. Pr(ClassA) = 1.0; Pr(ClassB) = 0.0), 
or at minimum, provided a distinctively high prob-
ability to a given class versus all others (e.g. 0.95 ver-
sus 0.05). Model fit was evaluated using information 
criteria fit indices (Bayesian Information Criterion, BIC 
and Akaike’s Information Criterion, AIC); and low val-
ues indicate model parsimony [21]. We also used other 
criteria to identify a meaningful fit of model and data, 
and these included class interpretability (the extent to 
which additional classes provided unique information), 
class prevalence (preferring classes with at least 2% of 
the sample for improved replicability), and entropy (a 
measure of classification based on posterior probability 
values, with higher values representing better classifi-
cation). We used analysis of variance and Chi-Square 
statistical analysis, which provides analysis of depend-
encies between data, establishing a hierarchical rela-
tionship, and displaying them in a two-dimensional 
graphical form. The two main factorial axes identified 
were the psychological state (ranging from good men-
tal health to worsened mental health) and the need for 
respiratory assistance (starting from no assistance to 
respiratory assistance such as oxygen or non-invasive 
ventilation).
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Statistical analysis
The calculation of the sample was based on the sampling 
strategy without experimental treatment. The sample 
size was calculated using the following formula: minimal 
sample size to obtain significant results for an event and 
a fixed level of risk: n = 100 X  t2 × p × (1-p) /  m2n, with 
t: Confidence level, the standard value for the 95% con-
fidence level will be 1.96, p: estimated proportion of the 
population with the characteristic of interest, m: Mar-
gin of error (usually set at 5%). Previous studies indicate 
that sexual dissatisfaction affects between 67.7% and 81% 
of COPD patients. Thus, for an event with a 60% prob-
ability of occurrence, and taking a 95% confidence level 
and a 5% margin of error, the sample size should be: 
n = 100 × 1.962 × 0.4 × 0.6 / 0.052 = 368.79. We should 
have at least 369 subjects and we included more than 
700. Qualitative variables were described in numbers 
and percentages. Quantitative variables were described 
by mean and standard deviation or median and inter-
quartile range. Missing data are reported in the tables. 
Differences in clinical characteristics were assessed using 
chi-square tests or Fisher’s exact tests, as appropriate, for 
discrete variables, and Wilcoxon or Kruskal–Wallis tests 
for quantitative variables. Relationships between differ-
ent variables were examined with the Pearson correla-
tion test. A value of p ≤ 0.05 was considered statistically 
significant.
The analysis of the results was carried out with Graph 
Pad Prism® statistical software.
Results
Responders
Seven hundred and fifty one patients responded to the 
survey. Participants were predominantly women (51% 
of patients) with a mean age of 61 years old and 62% of 
them lived as a couple. The majority of the participants 
were retired (70%). Every COPD grade was represented 
and one third of responders received oxygen. Only a 
quarter of the responders lived in an urban setting. Clini-
cal characteristics are reported in Table 1.
Sexual activities
Forty percent had no sexual activity among which, 19% 
lived as a couple. From the remaining 60%, 74% had to 
change their rhythm, 64% their frequency and 64% their 
position. Two thirds of the participants were dissatisfied 
with their current and expected sexual function and 13% 
declared that they used specific medications to improve 
their sexual performance. Forty three percent used rou-
tinely (17%) or occasionally (26%) a short-acting bron-
chodilator before sexual activity. Expressed reasons of 
sexual dissatisfaction were breathlessness, fatigue and 
physical problems. Men were more often dissatisfied with 
their current and expected sexual function (66% of men 
vs 53% of women, p = 0.0002), however it did not trans-
late into more medication, especially bronchodilators 
Table 1 Characteristics of the studied population
Missing data: a = 4, b = 114, c = 5, c = 103, e = 96
ASEX Arizona Sexual Experience Scale, FSS Fatigue severity scale HAD hospital 




Age (years) 61 [24–91]
Gender (male) 368 (49%)
Living as a couple 466 (62%)
Living area
 Urban 197 (26%)
 Suburban 233 (31%)
 Rural 317 (42%)a
Socioprofessional categories
 Farmer 4 (0.5%)
 Craftsperson, storekeeper, company head 66 (8.8%)
 Executive 123 (16.4%)
 Employee 267 (35.6%)
 Inactive/non‑working 70 (9.3%)
 Worker 72 (9.6%)
 Technician 149 (19.8%)
FEV1 (%)
 FEV1 ≥ 80% 52 (7%)
 50% < FEV1 ≤ 80% 225 (30%)
 30% < FEV1 ≤ 50% 278 (37%)
 FEV1 ≤ 30% 173 (23%)
Number of moderate to severe exacerbations in the 
previous year
1.95
Daily inhaled therapy 661 (88%)
Oxygenotherapy 233 (31%)
Ventilation (NIV or CPAP) 210 (28%)
At least one comorbidity 481 (64%)
ASEX
 Sexual appetite
  Low 368 (49%)
  Absent 143 (19%)
 Sexual desire
  Low 330 (44%)
  Absent 120(16%)b
Erectile dysfunction 451 (60%)
VQ11 34,8 [29.8–37.1]c
HAD
HAD‑A 10 [8, 9]
HAD‑D 8 [5, 6]d
Anxiety HAD A ≥ 10 340 (45%)
Depression HAD D ≥ 10 210 (28%)
FSS 4.67 [3.1–6.24]e
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(which respectively concerned 28% of men and 22% 
of women). Besides, the level of sexual dissatisfaction 
(assessed by the following evaluation: “improved, stable, 
worsened”) was unrelated to age (p = 0.391) or gender 
(p = 0.92, Table 2).
ASEX score revealed an altered sexual appetite: low 
for 49% of the subjects and absent for 19%. Sexual desire 
was compromised in 44% of the subjects and 16% lost all 
desire. However, the deterioration of sexual appetite or 
sexual desire, assessed with ASEX questionnaire, is not 
linked to airflow obstruction (Fig.  1f, g). Subjects with 
COPD had to make adaptations to compensate for their 
diminishing activity tolerance, increasing dyspnea, role 
and sexual self-image, anxiety, and increased need for 
communication.  Self-reported libido loss and reduced 
sexual performance worsened over time for 67% of the 
responders.
Quality of life and depression and anxiety
Based on the cut-off of 22 for VQ11 score, quality of life 
was altered among responders with a mean score of 34.8. 
The increase in airflow obstruction severity was inversely 
proportional to the quality of life, as assessed with VQ11 
augmentation (Fig.  1a). Impaired quality of life (defined 
as VQ11 ≥ 22) is significantly more frequent among 
responders with a higher airflow obstruction (Fig.  1b). 
Specific underscores, including psychological, functional 
and relational components of quality of life, indicate that 
every aspect of life is impaired and an increasing with 
airflow obstruction further impairs the quality of life 
(Fig. 1c-e).
Mental disorders such as anxiety and depression 
were associated with COPD severity in the respond-
ers. A mean score of 4.6 on the FSS scale translates into 
a depressive tendency in patients and FSS mean score 
increases with airflow obstruction severity, as shown 
in Fig.  2a. Similarly, HAD scale found high propor-
tions of patients with suspected anxiety or depression 
with a mean score of 10 and 8 for HAD-A and HAD-D 
respectively. HAD mean score for depression underscore 
increased with airflow severity (Fig. 2c) but the same was 
not reflected in HAD mean score for anxiety (Fig.  2b). 
However, both HAD scores for anxiety and depression 
increased when responders had at least two episodes of 
bronchitis in the previous year (Fig. 2d, e).
Mental disorders are also associated with sexual dissat-
isfaction. Higher depression as assessed by HAD under-
score for depression was strongly indicative of decreased 
sexual appetite and to a lesser extent anxiety as assessed 
with HAD underscore for anxiety (Fig. 2f, g). Inversely, a 
higher impairment of sexual desire caused an increase in 
depression and anxiety (Fig. 2h, i).
Sexuality remains taboo
Discussion of sexual issues remains a cultural taboo. 
Ninety percent of the responders declared that sexual 
dysfunction had never been discussed by doctors (gen-
eral practitioners or pulmonologists) and only 6% had a 
specialized consultation whereas 36% of them declared 
that they would have liked a specialized consultation with 
a sexologist. Twenty one percent would be willing for an 
online consultation.
Psychological profiles
We carried out typological analyses to split the popula-
tion studied into distinct homogeneous groups depend-
ing on their responses to the different questionnaires. 
This allowed us to combine the individuals into distinct 
homogeneous groups. We were able to isolate five behav-
ioral profiles: Group A Preoccupied (22%), Group B Dis-
couraged (19%), Group C Resigned (23%), Group D Naive 
(12%) and Group E Familiarized (24%). The map in Fig. 3 
provides a pictorial representation of these 5 profiles.
The patients in group A were predominantly female, 
active, less than 60 years old, with recently diagnosed and 
non-severe COPD. These patients had a moderate physi-
cal impact of COPD, suffering from symptoms of depres-
sion and anxiety.
The patients in group B were also predominantly 
female, but polymorbid, suffering from severe COPD 
requiring respiratory assistance. They can no longer, or 
with difficulty, maintain a sexual life, and have important 
psychological symptoms leading to social isolation. The 
physical impact of COPD, but above all psychological 
Table 2 Characteristics of the studied population according to sexual satisfaction
Data are provided as %. Differences in clinical characteristics were assessed using chi-square tests
Improved Stable Worsened P
Gender
Male/female
3%/4% 29%/29% 68%/67% 0.92
Age
24–49/50–59/60–69/ > 70 (years)
5%/3%/5%/1% 31%/25%/34%/26% 64%/72%/61%/73% 0.391
Living as a couple (Yes/no) 4%/3% 29%/30% 67%/67% 0.978
Occupation (Yes/no) 2%/5% 32%/28% 66%/67% 0.417





Fig. 1 Quality of life, assessed by VQ11 and sexual satisfaction, assessed by ASEX score according to airflow obstruction, assessed by FEV1. a 
VQ11 total score according to airflow obstruction, assessed by FEV1. b airflow obstruction according to VQ11 threshold (at 22 points). c VQ11 
psychological underscore according to airflow obstruction, assessed by FEV1. d VQ11 relational underscore according to airflow obstruction, 
assessed by FEV1. e VQ11 functional underscore according to airflow obstruction, assessed by FEV1. f Sexual appetite (ASEX) according to airflow 
obstruction, assessed by FEV1. g Sexual desire (ASEX) according to airflow obstruction, assessed by FEV1






Fig. 2 Mental disorder such as anxiety and depression are associated with COPD severity in the responders. a FSS total score according to airflow 
obstruction, assessed by FEV1. b Anxiety, assessed with HAD‑anxiety subscore according to airflow obstruction, assessed by FEV1. c Depression, 
assessed with HAD‑depression subscore according to airflow obstruction, assessed by FEV1. d Anxiety, assessed with HAD‑anxiety subscore 
according to the number of bronchitis. e Depression, assessed with HAD‑depression subscore according to the number of bronchitis. f Sexual 
appetite (ASEX) according to depression, assessed by HAD‑depression. g Sexual appetite (ASEX) according to anxiety, assessed by HAD‑anxiety. h 
Sexual desire (ASEX) according to depression, assessed by HAD‑depression. i Sexual desire (ASEX) according to anxiety, assessed by HAD‑anxiety
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and relational impact within this subgroup was clearly 
evident (extreme right-hand side of the graph).
The patients in group C were older than 70, with a long 
history of severe COPD, requiring daily ventilation. The 
degradation of their emotional and sexual life could be 
attributed to inactivity, breathlessness and substantial 
fatigue. They suffered mainly from physical symptoms, 
which explain their position at the top of the graph. How-
ever, they displayed only minor psychological symptoms.
The patients in group D were young and active, with 
recently diagnosed, non-severe COPD not requiring any 
respiratory assistance. Their sexual life was unaffected 
and for the disease did not require any life modification. 
Their social and emotional lives were normal. This group 
is situated at the lower left quadrant of the graph, dis-
playing low limitations on the two axes.
Finally, the patients in group E were elderly, suffered 
from a longstanding moderate COPD. They remained 
active despite breathlessness. They were not worried or 
anxious, and tried to adapt according to their respiratory 
capacity. These were patients with physical symptoms 
largely, albeit of a moderate nature.
Discussion
Till date, our study is the largest one to focus exclusively 
on sexual health in COPD patients. As reported previ-
ously, more than two thirds of patients with COPD had 
sexual dissatisfaction [11]. In a Taiwanese cohort study 
of 57,928 participants, patients with COPD had 1.88-
fold more sexual problems than patients without COPD 
[22]. Most of the previous studies have focused on male 
impotence, and only two studies included women with 
COPD [8–10], however our study indicates a dissatisfac-
tion related to sexual activity within both genders. These 
findings suggest that active care and attention should be 
directed to the sexual function and sexual satisfaction of 
COPD female patients as well as male patients. We also 
found that sexual activity of COPD patients in our cohort 
was related to the same factors that are of importance in 
a healthy population, namely: gender, partner status (sin-
gle or in couple) and age [4, 10, 23, 24].
Sexual dysfunctions are highly prevalent in both sexes, 
ranging from 10 to 52% of men and 25% to 63% of women 
[25, 26]. Sexual dysfunction is usually strongly related to 
age and health status [27]. Several studies have examined 
the impact of chronic diseases on sexual dysfunction 
and erectile dysfunction has been described as a “senti-
nel symptom” of several chronic diseases (hypertension, 
diabetes, ischemic heart disease) [3]. For example, hyper-
tension significantly increases sexual dysfunction (odds 
ratio = 2.789, p = 0.002) compared with the normotensive 
group [28]. However the effect of intensive blood pres-
sure lowering is moderate (p for interaction = 0.0016, 
[29]). Diabetes is also one of the most frequent organic 
causes of sexual dysfunction affecting around 20 to 36% 
of subjects [30]. COPD and cardiovascular or metabolic 
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A/PREOCCUPIED 22%
=> Moderate physical impact of 
COPD but increasing 
psychological weakness. 
D/NAIVE 12%
=> Dawning impact of COPD on 


















Fig. 3 Mapping of individuals gave a representation of their psychological profile
Page 8 of 10Zysman et al. Respir Res          (2020) 21:311 
diseases also seem to affect sexual function. This could 
be owing to the shared common pathways between the 
mechanisms underlying sexual dysfunction and the men-
tioned. Considering biological mechanisms; high  lev-
els  of  inflammatory  markers  such  as  TNFα  have been 
described in both COPD and sexual dysfunction [6], and 
chronic hypoxia, systemic/endothelial inflammation, 
hormonal imbalances (hypogonadism or lower testoster-
one levels) have also been considered to be possible con-
tributing factors [31].
Moreover, the link between sexual dysfunction and 
COPD may be the consequence of a decreased physical 
activity in patients leading to deconditioning. Experience 
of sexual dysfunction is more likely among women and 
men with poor physical health [24]. In agreement with 
this hypothesis we found that airflow obstruction sever-
ity is associated with sexual disability, although we did 
not perform exercise test among participants to clearly 
establish a link between physical inactivity and sexual 
dysfunction.
Nevertheless, respiratory or physical symptoms, such 
as dyspnea, cough, weakness, and reduced physical activ-
ity or fear of breathing difficulty, were reported to affect 
sexual activity, lowering the QoL of responders and 
COPD patients in general. For many patients, the libido 
loss triggers a sense of shame, which can reduce their 
self-esteem and cause depression. This study also con-
firms that individuals with COPD are at higher risk for 
developing depression [32] and subsequent worsening of 
sexual dysfunction.
Although doctors are reluctant to address the topic of 
sexuality in practice, our data suggest that patients want 
their doctors to address these concerns and provide 
resources to them. Despite the high incidence of sexual 
dissatisfaction among COPD patients, only 6% had talked 
about sexuality with a specialist. However, many clini-
cians may lack some of the basic skills needed to confi-
dently address these concerns [33]. Additionally, doctors 
should be proactive in initiating conversations on sexual 
issues to fill this gap. In practice, evaluation of quality 
of life in patients with COPD is currently being taking 
into account; however doctors and generally healthcare 
professionals need to integrate sexual well-being as an 
important component of quality of life.
This study has some limitations. The questionnaire 
results are, by definition, declarative, which may be a 
source of bias. Nevertheless, in order to alleviate this 
limitation we compared responders’ clinical charac-
teristics to those in large international COPD cohort, 
such as ECLIPSE. Airflow obstruction assessed by FEV1 
is similar in our population as compared to ECLIPSE 
cohort; GOLD stages 2, 3 and 4 affected 30, 37 and 23% 
in our population and 44, 42 and 14% in ECLIPSE [34]. 
Similarly, exacerbation rates in the previous year were 
also similar with 1.21 in ECLIPSE [35] as compared to 
1.95 in our population. The same repartition of airflow 
obstruction stages was observed with French COPD 
cohort initiative BPCO or PALOMB [36, 37] assuring a 
better reproducibility of our data. Another limitation is 
the lack of objective parameters to measure COPD sever-
ity such as centralized spirometry. Responders include 
patients coming from both urban and rural and a wide 
range of—occupational categories but unfortunately 
we did not collect data about their level of education. 
We also have no data about history of sexual dysfunction, 
hence unable to  ascertain  whether sexuality  difficulties 
occurred  prior  to or  after COPD  diagnosis. Co-mor-
bidities frequently associated with COPD [32], can also 
be involved in sexual dysfunction such as hypertension, 
chronic cardiovascular disease diabetes and obesity or 
sedentary lifestyle [38] were also not recorded. It is there-
fore difficult to determine the attributable share of COPD 
in sexual dysfunction.  Future  studies  should  examine 
changes in patient’s sexual disability over time according 
to COPD progression.
Conclusions
Sexual dysfunction is frequent among COPD patients 
and often neglected. Healthcare workers should strive 
to discuss sexual problems with patients suffering from 
COPD and offer sexual guidance as a means to improve 
quality of sexual life. Particular attention should be 
paid to women sexual dissatisfaction which is often 
under-estimated.
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